Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.
Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.
According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.
It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.


Thailand and Cambodia agree to 'consolidate ceasefire' in China talks
Indonesia fire kills 16 people in retirement home
Trump says US and Ukraine 'a lot closer' on peace deal but "thorny issues" remain
China launches war games around Taiwan as island vows to defend democracy
At least 13 dead, 98 injured in Mexico train derailment
South Korean president vows to reveal truth on anniversary of Jeju Air crash
Trump, Netanyahu to discuss next phase of Gaza plan
Arab League Council condemns Israel’s recognition of Somaliland
